In a pooled investigation of 624 MM patients and 1,246 controls from seven cohorts, Hofmann et al. revealed that serum adiponectin levels were lower among the patients than controls (medians of 11.5 and 12.8 μg/mL, respectively; p = 0.001). Here, ADIPOQ is linked to Miyoshi myopathy.